Pregled bibliografske jedinice broj: 1159314
Exercise Reveals Proline Dehydrogenase as a Potential Target in Heart Failure
Exercise Reveals Proline Dehydrogenase as a Potential Target in Heart Failure // Progress in Cardiovascular Diseases, 62 (2019), 2; 193-202 doi:10.1016/j.pcad.2019.03.002 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1159314 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Exercise Reveals Proline Dehydrogenase as a
Potential Target in Heart Failure
Autori
Moreira, Jose B.N. ; Wohlwend, Martin ; Fenk, Simone ; Åmellem, Ingrid ; Flatberg, Arnar ; Kraljevic, Jasenka ; Marinovic, Jasna ; Ljubkovic, Marko ; Bjørkøy, Geir ; Wisløff, Ulrik
Izvornik
Progress in Cardiovascular Diseases (0033-0620) 62
(2019), 2;
193-202
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Exercise ; Heart failure ; Hypoxia ; Mitochondria ; Physical activity
Sažetak
The benefits of physical activity in cardiovascular diseases have long been appreciated. However, the molecular mechanisms that trigger and sustain the cardiac benefits of exercise are poorly understood, and it is anticipated that unveiling these mechanisms will identify novel therapeutic targets. In search of these mechanisms we took advantage of unbiased RNA-sequencing (RNA-seq) technology to discover cardiac gene targets whose expression is disrupted in heart failure (HF) and rescued by exercise in a rat model. Upon exhaustive validation in a separate rat cohort (qPCR) and human datasets, we shortlisted 16 targets for a cell-based screening, aiming to evaluate whether targeted disruption of these genes with silencing RNA would affect the abundance of a CVD biomarker (BNP, B-type natriuretic peptide) in human cardiomyocytes. Overall, these experiments showed that Proline Dehydrogenase (PRODH) expression is reduced in human failing hearts, rescued by exercise in a rat model of HF, and its targeted knockdown increases BNP expression in human cardiomyocytes. On the other hand, overexpression of PRODH increases the abundance of metabolism-related gene transcripts, and PRODH appears to be crucial to sustain normal mitochondrial function and maintenance of ATP levels in human cardiomyocytes in a hypoxic environment, as well as for redox homeostasis in both normoxic and hypoxic conditions. Altogether our findings show that PRODH is a novel molecular target of exercise in failing hearts and highlight its role in cardiomyocyte physiology, thereby proposing PRODH as a potential experimental target for gene therapy in HF.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE